XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award  
Transactions under the Company's stock option plans

    

    

    

Weighted

    

Weighted 

average

average 

remaining

Aggregate

exercise

contractual 

intrinsic

Shares

price

life in years

value

Outstanding at December 31, 2019

 

614,311

$

14.78

 

6.9

$

4,783,402

Options granted

 

151,500

 

19.80

 

  

 

  

Options exercised

 

(63,011)

 

7.16

 

  

 

  

Options forfeited

 

(30,000)

 

19.50

 

  

 

  

Options expired

 

 

 

  

 

  

Outstanding at December 31, 2020

 

672,800

$

16.42

 

6.8

$

1,952,568

Options granted

 

89,000

 

19.21

 

 

Options exercised

 

(71,267)

 

8.84

 

 

Options forfeited

 

(2,000)

 

18.64

 

 

Options expired

 

 

 

 

Outstanding at December 31, 2021

 

688,533

$

17.56

 

6.6

$

5,986,666

Options granted

 

 

 

 

Options exercised

 

(115,538)

 

14.70

 

 

Options forfeited

 

(13,496)

 

19.75

 

 

Options expired

 

 

 

 

Outstanding at December 31, 2022

 

559,499

$

18.09

 

5.9

$

5,168,740

Exercisable at December 31, 2022

455,014

$

17.76

 

5.5

$

4,353,237

Schedule of fair values of the options granted

The fair values of the options granted during 2021 and 2020 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions. There were no options granted during 2022.

For the years ended December 31, 

 

    

2022

    

2021

    

2020

 

Number of options granted

 

 

89,000

 

151,500

Weighted average exercise price

$

$

19.21

$

19.80

Weighted average fair value of options

$

$

7.72

$

6.12

Expected life in years (1)

 

 

8.38

 

8.50

Expected volatility (2)

 

%  

 

43.69

%  

 

32.69

%

Risk-free interest rate (3)

 

%  

 

1.14

%  

 

1.28

%

Dividend yield (4)

 

%  

 

1.68

%  

 

1.64

%

(1)The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding.
(2)The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options.
(3)The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant.
(4)The expected dividend yield is the projected annual yield based on the grant date stock price.
Schedule of Information About Options Exercised

Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during 2022, 2021 and 2020:

For the years ended December 31, 

    

2022

    

2021

    

2020

Number of options exercised

 

115,538

 

71,267

 

63,011

Total intrinsic value of options exercised

$

1,614,421

$

974,776

$

564,314

Cash received from options exercised

1,698,357

630,302

451,420

Tax deduction realized from options

485,698

293,261

169,774

Schedule of Stock Options, by Exercise Price Range

The following table summarizes information about stock options outstanding and exercisable at December 31, 2022:

Options outstanding

Options exercisable

    

Weighted average 

    

Weighted 

    

    

Weighted

Options

remaining contractual 

average 

Options

average

Range of exercise prices

outstanding

life (in years)

exercise price

exercisable

exercise price

$7.25 - $16.51

 

140,533

 

4.0

$

11.93

 

128,867

$

11.54

$16.52 - $19.26

 

135,166

 

6.8

18.08

 

97,013

18.16

$19.27 - $20.88

 

143,500

 

6.5

20.30

 

110,834

20.22

$20.89 - $22.57

 

140,300

 

6.4

22.02

 

118,300

21.92

Total

 

559,499

 

5.9

$

18.09

 

455,014

$

17.76

Schedule of Nonvested Share Activity

    

    

Average grant

Shares

date fair value

Nonvested restricted stock at December 31, 2021

 

119,487

$

21.00

Granted

 

97,700

 

27.48

Cancelled

 

(11,587)

 

23.29

Vested

 

(41,030)

 

20.68

Nonvested restricted stock at December 31, 2022

 

164,570

$

24.77

Restricted Stock Awards Activity

Restricted stock awards granted during the years ended December 31, 2022, 2021 and 2020 were as follows:

For the years ended December 31,

    

2022

    

2021

    

2020

Number of shares granted

 

97,700

 

68,550

 

27,250

Average grant date fair value

$

27.48

$

22.15

$

17.12

Summary of Components of Net Periodic Pension Cost of Defined Benefit Plan Recognized

For the years ended December 31, 

(In thousands)

    

2022

    

2021

    

2020

Service cost

$

150

$

515

$

126

Interest cost

 

186

 

161

 

147

Amortization of prior service cost

 

 

332

 

83

Net periodic benefit cost

$

336

$

1,008

$

356

Summary of Changes in Benefit Obligations of Defined Benefit Plan Recognized

The following table summarizes the changes in benefit obligations of the defined benefit plan recognized during the years ended December 31, 2022, 2021 and 2020

For the years ended December 31, 

(In thousands)

    

2022

    

2021

    

2020

Benefit obligation, beginning of year

$

4,521

$

3,845

$

3,572

Service cost

 

150

 

515

 

126

Interest cost

 

186

 

161

 

147

Benefit obligation, end of period

$

4,857

$

4,521

$

3,845

Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs

For the years ended December 31,

    

2022

    

2021

    

2020

Compensation expense

$

567

$

867

$

744

Income tax benefit

164

251

215

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs

For the years ended December 31, 

    

2022

    

2021

    

2020

Compensation expense

$

1,114

$

750

$

667

Income tax benefit

$

320

$

217

$

193